Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurberry Regulatory News (BRBY)

Share Price Information for Burberry (BRBY)

Share Price is delayed by 15 minutes
Get Live Data
1,137.50    20.50 (1.84%)
Bid:
1,129.50
Ask:
1,132.50
Spread: 3.00 (0.266%)
Market Cap: £4.09b
BRBY Live PriceLast checked at - London Stock Exchange

Intraday Burberry Share Chart

Board Change

20 Oct 2021 07:00

RNS Number : 6066P
Burberry Group PLC
20 October 2021
 

BURBERRY GROUP PLC

("Burberry" or the "Company")

 

BOARD CHANGE

 

 

BURBERRY APPOINTS JONATHAN AKEROYD AS CHIEF EXECUTIVE OFFICER

 

 

Burberry today announces the appointment of Jonathan Akeroyd as Chief Executive Officer and Executive Director, effective 1 April 2022.

 

A British national, Jonathan, 54, is currently Chief Executive Officer of Milan-based Gianni Versace SpA, a position he has held since June 2016. In his tenure at Versace, Jonathan has reorganised and accelerated growth at the iconic Italian fashion house, building on the brand's rich creative heritage to elevate product, communications and the customer experience.

 

Jonathan was previously Chief Executive Officer of Alexander McQueen from 2004 to 2016, during which time he led a turnaround of the British luxury brand and laid the foundation for global expansion. He has also held a number of senior fashion roles at London-based luxury department store Harrods. Jonathan will join Burberry on 1 April 2022 and will report to Chair Gerry Murphy and the Board of Directors.

 

Gerry Murphy, Chair of Burberry commented:

"I am delighted that Jonathan Akeroyd will be joining Burberry as our next Chief Executive Officer. Jonathan is an experienced leader with a strong track record in building global luxury fashion brands and driving profitable growth. He shares our values and our ambition to build on Burberry's unique British creative heritage and his deep luxury and fashion industry expertise will be key to advancing the next phase of Burberry's evolution."

 

Jonathan Akeroyd said:

"I am honoured to be joining Burberry as Chief Executive Officer. I have long admired Burberry's position as the most iconic British luxury brand and I have a deep affection for its storied heritage. I am looking forward to returning to London where I first built my career in the luxury industry to join a talented team with ambitious plans for the future and a strong platform to accelerate growth."

 

Jonathan will succeed Marco Gobbetti as Burberry Chief Executive Officer. Marco will step down from the role and leave Burberry on 31 December 2021. Gerry Murphy will chair the Executive Committee from this date until Jonathan joins Burberry.

 

This announcement contains information that qualified or may have qualified as inside information and is disclosed in accordance with the Market Abuse Regulation (EU) 596/2014 ("MAR"). For the purposes of MAR, this announcement is made by Gemma Parsons, Company Secretary.

 

There are no other matters to be disclosed under listing rule 9.6.13R in relation to Jonathan's appointment.

 

Additional information

 

Remuneration Arrangements

 

Jonathan's remuneration arrangements have been set in accordance with the Directors' Remuneration Policy approved by shareholders at the AGM on 15 July 2020.

 

This will include a salary of £1,100,000 per annum and an annual cash benefits allowance of £50,000. Jonathan will be eligible for a target bonus of 100% of salary and maximum of 200% of salary and a Burberry Share Plan award of 162.5% of salary. His pension entitlement will align with arrangements for the majority of the UK workforce.

 

Jonathan will also be granted cash and share awards which are due to vest in FY 2021/22, 2022/23, 2023/24 and 2024/25 to compensate for share and cash incentives from his current employer that he will forfeit on joining Burberry. The aggregate value of the buyout awards is approximately £6 million. These buyout awards are in line with the type of award, amount and deferral schedule of the awards being forfeited by Jonathan, full details of which will be disclosed in Burberry's FY 2021/22 Annual Report.

 

 

20 October 2021

 

Enquiries

 

Investor and analysts

Julian Easthope VP, Investor Relations

020 3367 4458

Julian.Easthope@burberry.com

 

Media

Andrew Roberts VP, Corporate Relations

020 3367 3764

Andrew.Roberts@burberry.com

 

 

This announcement does not constitute an invitation to underwrite, subscribe for or otherwise acquire or dispose of any Burberry Group plc shares, in the UK, or in the US, or under the US Securities Act 1933 or in any other jurisdiction.

 

Burberry is listed on the London Stock Exchange (BRBY.L) and is a constituent of the FTSE 100 index. ADR symbol OTC:BURBY.

 

BURBERRY, the Equestrian Knight Device, the Burberry Check and the Thomas Burberry Monogram and Print are trademarks belonging to Burberry.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAMMBMTMTJTMTB
Date   Source Headline
10th Jun 20264:52 pmRNSDirector Declaration
9th Jun 202611:30 amRNSHolding(s) in Company
1st Jun 202610:15 amRNSIssue of Shares & Total Voting Rights
28th May 202610:45 amRNSAnnual Financial Report
14th May 20267:01 amRNSBoard changes
14th May 20267:00 amRNSBurberry FY26 Preliminary Results
1st May 202612:20 pmRNSIssue of Shares & Total Voting Rights
29th Apr 20262:45 pmRNSDirector Declaration
10th Apr 20263:40 pmRNSHolding(s) in Company
9th Apr 202611:30 amRNSHolding(s) in Company
1st Apr 20265:30 pmRNSIssue of Shares & Total Voting Rights
1st Apr 202612:15 pmRNSHolding(s) in Company
20th Mar 202612:31 pmRNSDirector/PDMR Shareholding
20th Mar 202610:25 amRNSIssue of Equity
19th Mar 20266:00 pmRNSHolding(s) in Company
5th Mar 20264:40 pmRNSHolding(s) in Company
2nd Mar 202611:00 amRNSTotal Voting Rights
12th Feb 20262:00 pmRNSHolding(s) in Company
10th Feb 202610:30 amRNSHolding(s) in Company
2nd Feb 20262:00 pmRNSTotal Voting Rights
27th Jan 20265:00 pmRNSHolding(s) in Company
22nd Jan 202612:30 pmRNSHolding(s) in Company
21st Jan 20267:00 amRNSThird Quarter Trading Update
9th Jan 202612:30 pmRNSHolding(s) in Company
2nd Jan 202611:30 amRNSTotal Voting Rights
18th Dec 20252:01 pmRNSHolding(s) in Company
18th Dec 20252:01 pmRNSHolding(s) in Company
12th Dec 20259:15 amRNSDirector/PDMR Shareholding
2nd Dec 20255:40 pmRNSHolding(s) in Company
1st Dec 20251:30 pmRNSTotal Voting Rights
24th Nov 20255:30 pmRNSHolding(s) in Company
20th Nov 20254:20 pmRNSHolding(s) in Company
19th Nov 20255:36 pmRNSHolding(s) in Company
18th Nov 20256:07 pmRNSHolding(s) in Company
13th Nov 20255:27 pmRNSHolding(s) in Company
13th Nov 20257:00 amRNSBurberry Interim Results
3rd Nov 20252:43 pmRNSTotal Voting Rights
28th Oct 20254:50 pmRNSHolding(s) in Company
15th Oct 20255:38 pmRNSHolding(s) in Company
10th Oct 202512:07 pmRNSHolding(s) in Company
2nd Oct 20253:10 pmRNSHolding(s) in Company
1st Oct 202510:30 amRNSTotal Voting Rights
25th Sep 20256:00 pmRNSHolding(s) in Company
5th Sep 20256:21 pmRNSBlock listing Interim Review
5th Sep 20255:45 pmRNSDirector/PDMR Shareholding
1st Sep 202512:14 pmRNSTotal Voting Rights
13th Aug 20253:04 pmRNSHolding(s) in Company
1st Aug 202511:58 amRNSTotal Voting Rights
31st Jul 20254:55 pmRNSDirector/PDMR Shareholding
18th Jul 20255:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.